Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +82.74% | +29.65% | -84.54% | -83.13% | -82.79% |
| Weighted Average Shares Diluted Growth | +82.74% | +29.65% | -84.54% | -83.13% | -82.79% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +41.06% | -19.60% | -27.52% | -41.94% | -49.38% |
| Book Value per Share Growth | +0.00% | -44.89% | +249.00% | +242.40% | +221.94% |
| Debt Growth | -15.56% | -25.63% | -35.67% | -57.23% | -52.62% |
| R&D Expense Growth | +79.03% | +156.80% | +75.74% | -33.68% | -93.00% |
| SG&A Expenses Growth | +26.28% | -4.65% | -8.94% | +9.35% | +0.27% |